Adherex Trials - Recruiting and Closed listed at Clinicaltrials.gov on June23 2007

Include trials that are no longer recruiting patients.

8 studies were found.

1.		No longer recruiting	A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent Condition: Neoplasms
2.		Terminated	A Study of the Safety and Effects of ADH-1 Given Daily to Subjects With Solid Tumors Condition: Neoplasms
3.		No longer recruiting	Study of ADH-1 Given Intravenously to Patients With Solid Tumors Condition: Neoplasms
4.		Recruiting	A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors Condition: Neoplasms
5.		Completed	A Study of ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic Resection Condition: Neoplasms
6.		Recruiting	A Phase 1 Dose Escalation Study of ADH 1 in Combination With Carboplatin, or Docetaxel or Capecitabine Condition: Neoplasms
7.		Recruiting	A Phase 1 Dose Escalation Study of ADH-1 in Combination With Normothermic Isolated Limb Infusion of Melphalan Condition: Neoplasms
8.		Recruiting	A Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of ADH300004 and 5-Fluorouracil Administered Orally in a Weekly Schedule to Subjects With Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma Condition: Hepatocellular Carcinoma